Positive Phase 2 Trial Results from Neuroendocrine Tumor Cohort Presented at CIRSE
New York and Munich (ots/PRNewswire) - Chemosaturation Demonstrates Clinically Meaningful Tumor Response with Unresectable Neuroendocrine Tumors in the Liver Delcath Systems, Inc. announced that updated results from the metastatic neuroendocrine tumor (mNET) cohort of the Company's recently completed Phase 2 clinical trial were presented at the Cardiovascular and ...